Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neil Moudgill

Vascular Surgery Tampa, FL Medical Doctor

NPI 1649488099 CMS profile 346829

2 Tampa General Cir, Stc 3Rd Floor, Tampa, FL 33606

Open in the dashboard

General payments

$5,319

135 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Neil Moudgill of Tampa, FL is reported in the CMS Open Payments database as having received $5,319 across 135 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 51st percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $408 11
2024 General $531 15
2023 General $1,422 27
2022 General $1,080 17
2021 General $370 21
2020 General $406 17
2019 General $1,102 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neil Moudgill
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Neil Moudgill were reported at $408. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Neil Moudgill Vascular Surgery median Middle half National median
2019 $1,102 $796 $226–$2,363 $163
2020 $406 $348 $118–$1,110 $114
2021 $370 $471 $158–$1,421 $132
2022 $1,080 $725 $222–$2,183 $149
2023 $1,422 $836 $257–$2,440 $160
2024 $531 $909 $252–$2,619 $164
2025 $408 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $2,100 42 payments
  2. Cook Medical LLC $1,784 43 payments
  3. Medtronic Vascular, Inc. $671 23 payments
  4. Medtronic, Inc. $326 18 payments
  5. Penumbra, Inc. $268 2 payments
  6. LeMaitre Vascular, Inc. $36 1 payment
  7. Terumo Medical Corporation $33 1 payment
  8. Silk Road Medical, Inc. $32 2 payments
  9. CVRx, Inc. $29 1 payment
  10. Baxter Healthcare $25 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,319 135 payments
Products named General payments · program years 2019–2025
  1. Endurant Aortic Stent Grafts $671 23 payments
  2. GORE VIABAHN VBX Balloon Expandable Endo $660 5 payments
  3. Zenith Spiral-Z $510 6 payments
  4. GORE EXCLUDER AAA Endoprosthesis $386 12 payments
  5. Cook Medical Zilver PTX $347 10 payments
  6. EXCLUDER Conformable AAA Endoprosthesis with Active Control $328 10 payments
  7. Zilver PTX $299 9 payments
  8. Endurant Aortic Stent Grafts $270 15 payments
  9. GORE TAG Conformable Thoracic Endoprosthesis $212 5 payments
  10. Zenith $205 6 payments
  11. Other $1,463 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

135 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record